Dyrk1A has received particular attention because of its involvement not only in DS but also in several types of cancer, in which this kinase has been implicated in proliferation enhancement and reduction of cell death providing resistance to proapoptotic stimuli by chemotherapy or radiotherapy (49, 50). The gene discussed is DYRK1A; the disease is cancer.